JP2005504517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504517A5 JP2005504517A5 JP2002592353A JP2002592353A JP2005504517A5 JP 2005504517 A5 JP2005504517 A5 JP 2005504517A5 JP 2002592353 A JP2002592353 A JP 2002592353A JP 2002592353 A JP2002592353 A JP 2002592353A JP 2005504517 A5 JP2005504517 A5 JP 2005504517A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- variant
- variable region
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004965 antibodies Human genes 0.000 claims 23
- 108090001123 antibodies Proteins 0.000 claims 23
- 150000007523 nucleic acids Chemical group 0.000 claims 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 230000004927 fusion Effects 0.000 claims 8
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 6
- 239000000126 substance Substances 0.000 claims 6
- 230000036252 glycation Effects 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- WUAPFZMCVAUBPE-UHFFFAOYSA-N Rhenium Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 claims 2
- 231100000765 Toxin Toxicity 0.000 claims 2
- 229910052702 rhenium Inorganic materials 0.000 claims 2
- 239000003053 toxin Substances 0.000 claims 2
- 108020003112 toxins Proteins 0.000 claims 2
- 108020004511 Recombinant DNA Proteins 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 230000005250 beta ray Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims 1
- 229910052727 yttrium Inorganic materials 0.000 claims 1
Claims (22)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01112237 | 2001-05-18 | ||
US32514701P | 2001-09-26 | 2001-09-26 | |
PCT/EP2002/005467 WO2002094879A1 (en) | 2001-05-18 | 2002-05-17 | Antibodies specific for cd44v6 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005504517A JP2005504517A (en) | 2005-02-17 |
JP2005504517A5 true JP2005504517A5 (en) | 2006-01-05 |
Family
ID=33442672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002592353A Pending JP2005504517A (en) | 2001-05-18 | 2002-05-17 | CD44v6 specific antibody |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1397387A1 (en) |
JP (1) | JP2005504517A (en) |
CN (1) | CN1541226A (en) |
AR (1) | AR036154A1 (en) |
BR (1) | BR0210905A (en) |
CA (1) | CA2443437A1 (en) |
CZ (1) | CZ20033476A3 (en) |
EA (1) | EA200301169A1 (en) |
EC (1) | ECSP034838A (en) |
EE (1) | EE200300569A (en) |
HU (1) | HUP0400030A3 (en) |
MX (1) | MXPA03010523A (en) |
PE (1) | PE20021098A1 (en) |
PL (1) | PL365735A1 (en) |
SK (1) | SK15592003A3 (en) |
WO (1) | WO2002094879A1 (en) |
YU (1) | YU91403A (en) |
ZA (1) | ZA200307365B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8048416B2 (en) | 1999-10-08 | 2011-11-01 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7189397B2 (en) | 1999-10-08 | 2007-03-13 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20050100542A1 (en) | 1999-10-08 | 2005-05-12 | Young David S. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7947496B2 (en) | 1999-10-08 | 2011-05-24 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US8071072B2 (en) | 1999-10-08 | 2011-12-06 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
EP1716179A2 (en) | 2004-02-12 | 2006-11-02 | Morphotek, Inc. | Monoclonal antibodies that specifically bind to folate receptor alpha |
WO2006099141A2 (en) | 2005-03-10 | 2006-09-21 | Morphotek, Inc. | Anti-mesothelin antibodies |
WO2006116592A2 (en) | 2005-04-22 | 2006-11-02 | Morphotek, Inc. | Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
EA022911B1 (en) * | 2007-06-13 | 2016-03-31 | Займодженетикс, Инк. | Method for treatment of a patient suffering from i or ii stage of systemic lupus erythematosus |
EP2009028A1 (en) * | 2007-06-27 | 2008-12-31 | Monoclonal Antibodies Therapeutics | Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors |
WO2011095498A1 (en) | 2010-02-04 | 2011-08-11 | F. Hoffmann-La Roche Ag | A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
CN102337298B (en) * | 2011-08-19 | 2013-11-06 | 黄开红 | Immune nano-carrier for conveying siRNA (small interfering Ribonucleic Acid) and preparation method and application thereof |
WO2013083497A1 (en) | 2011-12-06 | 2013-06-13 | F. Hoffmann-La Roche Ag | Antibody formulation |
WO2017215637A1 (en) * | 2016-06-15 | 2017-12-21 | 李翀 | Human endometrial cancer marker, antibody, and application of antibody |
CN107556388A (en) * | 2016-06-30 | 2018-01-09 | 中国科学院深圳先进技术研究院 | The double targeting antibodies of anti-CD44v6 and CD3 specificity, the minicircle dna containing this pair of targeting antibodies expression cassette and application |
EP4301782A1 (en) * | 2021-03-05 | 2024-01-10 | Go Therapeutics, Inc. | Anti-glyco-cd44 antibodies and their uses |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
IL162181A (en) * | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
EP0438310A1 (en) * | 1990-01-19 | 1991-07-24 | Merck & Co. Inc. | Method for producing recombinant immunoglobuline |
GB9020282D0 (en) * | 1990-09-17 | 1990-10-31 | Gorman Scott D | Altered antibodies and their preparation |
CA2149635A1 (en) * | 1992-11-20 | 1994-06-09 | David Tarin | Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
UA58482C2 (en) * | 1994-06-08 | 2003-08-15 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | MONOCLONAL ANTIBODY VFF-18 AGAINST CD44v6 AND ITS FRAGMENTS |
UY24389A1 (en) * | 1995-12-06 | 2001-10-25 | Karlsruhe Forschzent | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FLAT EPITHELIUM CARCINOMA |
-
2002
- 2002-05-17 HU HU0400030A patent/HUP0400030A3/en unknown
- 2002-05-17 AR ARP020101830A patent/AR036154A1/en not_active Suspension/Interruption
- 2002-05-17 WO PCT/EP2002/005467 patent/WO2002094879A1/en not_active Application Discontinuation
- 2002-05-17 CZ CZ20033476A patent/CZ20033476A3/en unknown
- 2002-05-17 MX MXPA03010523A patent/MXPA03010523A/en unknown
- 2002-05-17 EP EP02735364A patent/EP1397387A1/en not_active Ceased
- 2002-05-17 YU YU91403A patent/YU91403A/en unknown
- 2002-05-17 CN CNA028101561A patent/CN1541226A/en active Pending
- 2002-05-17 EE EEP200300569A patent/EE200300569A/en unknown
- 2002-05-17 PL PL02365735A patent/PL365735A1/en not_active Application Discontinuation
- 2002-05-17 BR BR0210905-0A patent/BR0210905A/en not_active Expired - Fee Related
- 2002-05-17 EA EA200301169A patent/EA200301169A1/en unknown
- 2002-05-17 CA CA002443437A patent/CA2443437A1/en not_active Abandoned
- 2002-05-17 PE PE2002000422A patent/PE20021098A1/en not_active Application Discontinuation
- 2002-05-17 SK SK1559-2003A patent/SK15592003A3/en not_active Application Discontinuation
- 2002-05-17 JP JP2002592353A patent/JP2005504517A/en active Pending
-
2003
- 2003-09-22 ZA ZA200307365A patent/ZA200307365B/en unknown
- 2003-11-10 EC EC2003004838A patent/ECSP034838A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005504517A5 (en) | ||
KR100484084B1 (en) | Chimeric polypeptides, method for production and uses thereof | |
ES2346178T3 (en) | New compositions, procedures and uses of albumin binding | |
JP2006516189A5 (en) | ||
CO5570710A2 (en) | PEPTIDES THAT ACT AS GLON-RECEPTOR AGONISTS AND AS GLUCAGON RECEIVER ANTAGONISTS AND THEIR PHARMACOLOGICAL USE METHODS | |
WO2003000842A3 (en) | Novel proteins and nucleic acids encoding same | |
JP2002513556A5 (en) | ||
JP2013529070A5 (en) | ||
Gallizia et al. | Production of a Soluble and Functional Recombinant Streptavidin inEscherichia coli | |
WO2002055718A3 (en) | Assembly and screening of highly complex and fully human antibody repertoire in yeast | |
AR036154A1 (en) | SPECIFIC ANTIBODIES OF CD44V6. | |
Amano et al. | Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components | |
CA2461443A1 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
WO2002081498A3 (en) | Novel proteins and nucleic acids encoding same | |
JP2004526421A5 (en) | ||
Maruyama et al. | A novel domain sequence of connectin localized at the I band of skeletal muscle sarcomeres: homology to neurofilament subunits | |
ES2663242T3 (en) | Gene products differentially expressed in tumors and their use | |
Proost et al. | Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines | |
JP2011504361A5 (en) | ||
IL154102A (en) | Urocortin-related peptide, dna encoding same and pharmaceutical composition comprising same | |
WO2003010327A3 (en) | Novel proteins and nucleic acids encoding same | |
CN108610415A (en) | A kind of preparation method of antibody complex | |
US8003348B2 (en) | Method for the mass expression of an antimicrobial peptide by co-expression of a basic antimicrobial peptide and an acidic peptide using a translational coupling system | |
CA2284733A1 (en) | Motilin homologs | |
JP2020127419A5 (en) |